186 related articles for article (PubMed ID: 16467045)
1. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
[TBL] [Abstract][Full Text] [Related]
2. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nitrosative and oxidative stress in Behçet disease.
Bekpinar S; Kiliç N; Unlüçerçi Y; Akdag-Köse A; Azizlerli G; Ozbek-Kir Z
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):167-71. PubMed ID: 15752284
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum carbonyl and malondialdehyde levels following colchicine and vitamin E treatment in Behcet's disease.
Gulbahar O; Adisen H; Koca C; Aricioglu A; Gulekon A
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):521-4. PubMed ID: 18040527
[TBL] [Abstract][Full Text] [Related]
5. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Zitnanová I; Korytár P; Aruoma OI; Sustrová M; Garaiová I; Muchová J; Kalnovicová T; Pueschel S; Duracková Z
Clin Chim Acta; 2004 Mar; 341(1-2):139-46. PubMed ID: 14967170
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
[TBL] [Abstract][Full Text] [Related]
7. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease.
Onur E; Kabaroglu C; Inanir I; Var A; Guvenc Y; Gunay O; Gunduz K
Cutan Ocul Toxicol; 2011 Sep; 30(3):217-20. PubMed ID: 21345164
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
12. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.
Adişen E; Aral A; Aybay C; Gürer MA
Dermatology; 2008; 217(3):235-40. PubMed ID: 18663306
[TBL] [Abstract][Full Text] [Related]
13. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
[TBL] [Abstract][Full Text] [Related]
14. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
[TBL] [Abstract][Full Text] [Related]
16. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease.
Oh SH; Han EC; Lee JH; Bang D
Clin Exp Dermatol; 2009 Aug; 34(6):e208-12. PubMed ID: 19549229
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
19. Relationship between periodontal findings and Behçet's disease: a controlled study.
Akman A; Kacaroglu H; Donmez L; Bacanli A; Alpsoy E
J Clin Periodontol; 2007 Jun; 34(6):485-91. PubMed ID: 17451414
[TBL] [Abstract][Full Text] [Related]
20. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
